𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retrospective c-erbB-2 immunostaining in aspiration cytology of breast cancer

✍ Scribed by M. Jorda; P. Ganjei; M. Nadji


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
334 KB
Volume
11
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Fifty fine‐needle aspiration cytologies of breast that were diagnosed as carcinomas were retrieved from the files and retrospectively evaluated for the expression of c‐__erb__B‐2 oncoprotein using standard immunocytochemical methods. Corresponding histologic sections of all tumors were similarly studied.

Seventeen fine‐needle aspirates (34%) reacted positively for the presence of c‐__erb__B‐2 oncoprotein. All but one (32%) of the corresponding tissue sections were also positive for c‐__erb__B‐2 by immunohistochemistry. All positive cases were infiltrative ductal carcinomas with a preponderance of the comedo type. Positive reactions were localized in the cytoplasmic membrane of tumor cells. The staining was either present in all cells throughout a tumor, or it was completely absent. We conclude that immunocytochemistry for c‐__erb__B‐2 oncoprotein can be performed on fine‐needle aspiration cytology samples that are previously fixed and stained with the Papanicolaou technique. Furthermore, the sensitivity of immunostaining results are comparable to that obtained in histologic sections. Diagn Cytopathol 1994; 11:262–265. Β© 1994 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Prognostic value of c-erbB2 expression i
✍ Shinichi Tsutsui; Shinji Ohno; Shigeru Murakami; Yoichi Hachitanda; Shinya Oda πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views
Cytoplasmic staining of c-erbB-2 is not
✍ Susan L. Taylor; Angela Platt-Higgins; Philip S. Rudland; John H. R. Winstanley; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 223 KB πŸ‘ 2 views

The cell-surface receptor tyrosine kinase protein c-erbB-2 is immunocytochemically detected as membrane staining on the surface of cancer cells in 20-30% of cases of breast cancer, and its presence has been associated with poor prognosis for the patient. However, there have been numerous reports of

c-erbB-2 expression in FNAB smears and m
✍ G. Troncone; L. Panico; A. Vetrani; B. de Divitiis; P. Zeppa; F. Fulciniti; G. P πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 568 KB

Most of the data regarding the signijcance of c-erbB-2 oncogene expression as a prognostic marker in breast cancer have been generated in many large retrospective studies by retrieving the corresponding oncoprotein in archival parafin em bedded sections. Recent@. employing fresh breast cancer cells